NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
12/10/21 | 8-K | Current report filing |
![]() |
6 | |
11/29/21 | SEC STAFF LETTER | SEC Staff Letter |
![]() |
1 | |
11/26/21 | 3 | Initial statement of beneficial ownership of securities |
![]() |
1 | |
11/26/21 | 3 | Initial statement of beneficial ownership of securities |
![]() |
1 | |
11/26/21 | 3 | Initial statement of beneficial ownership of securities |
![]() |
1 | |
11/26/21 | 3 | Initial statement of beneficial ownership of securities |
![]() |
1 | |
11/26/21 | 3 | Initial statement of beneficial ownership of securities |
![]() |
1 | |
11/26/21 | 3 | Initial statement of beneficial ownership of securities |
![]() |
1 | |
11/12/21 | 8-K | Current report filing |
![]() |
22 | |
11/12/21 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
![]() |
172 |